Prof Victor Ck Tse, MD PHD in Seattle, WA - Medicare Neurological Surgery

Prof Victor Ck Tse, MD PHD is a medicare enrolled "Neurological Surgery" physician in Seattle, Washington. His current practice location is 550 17th Ave, 5th Floor, Seattle, Washington. You can reach out to his office (for appointments etc.) via phone at (206) 320-2800.

Prof Victor Ck Tse is licensed to practice in Washington (license number MD00049012) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1871629717.

Contact Information

	Prof Victor Ck Tse, MD PHD
	550 17th Ave, 5th Floor, Seattle, WA 98122-5788
	(206) 320-2800
	(206) 320-2827

Physician's Profile

Full Name	Prof Victor Ck Tse
Gender	Male
Speciality	Neurological Surgery
Location	550 17th Ave, Seattle, Washington
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1871629717
Provider Enumeration Date: 02/26/2007
Last Update Date: 01/11/2022

Medicare PECOS Information:

PECOS PAC ID: 1052416435
Enrollment ID: I20070412000544

Medical Identifiers

Medical identifiers for Prof Victor Ck Tse such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1871629717	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207T00000X	Neurological Surgery	MD00049012 (Washington)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Prof Victor Ck Tse allows following entities to bill medicare on his behalf.

Entity Name	Permanente Medical Group Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710

News Archive

Opioid, sedative and antidepressant use prior to surgery leads to more complications

A study led by University of Kentucky Markey Cancer Center researchers showed that patients who already used opioids, sedatives or antidepressants prior to colorectal surgery experience significantly more complications post-surgery.

New peptide derivatives that target the SARS-CoV-2 spike protein

In a new study published in the journal Cellular and Molecular Bioengineering, researchers report peptide derivatives, or peptidomimetics, based on the circle residues involved in the interaction of the spike protein and ACE2.

Mathematical model reveals how cell turnover determines the success of adaptive therapy

One of the most challenging issues in cancer therapy is the development of drug resistance and subsequent disease progression.

NCOA spearheads new initiative to help protect older adults from influenza

The National Council on Aging announced today it is spearheading a new initiative to help protect older adults from influenza this upcoming flu season. The educational program, Flu + You, in collaboration with Sanofi Pasteur, aims to educate older adults and their caregivers about the seriousness of influenza, the importance of annual influenza immunization, and available vaccine options.

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Using a technology called VirScan to study coronavirus antibody responses in a large cohort of SARS-CoV-2-infected and control individuals, researchers identified epitopes recognized by a large fraction of COVID-19 patients, epitopes cross-reactive with antibodies developed in response to other human coronaviruses, and 10 epitopes likely recognized by neutralizing antibodies.

Entity Name	University Of California San Francisco
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897

Opioid, sedative and antidepressant use prior to surgery leads to more complications

New peptide derivatives that target the SARS-CoV-2 spike protein

Mathematical model reveals how cell turnover determines the success of adaptive therapy

One of the most challenging issues in cancer therapy is the development of drug resistance and subsequent disease progression.

NCOA spearheads new initiative to help protect older adults from influenza

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Entity Name	Ucsf Medical Group Business Services
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513

Opioid, sedative and antidepressant use prior to surgery leads to more complications

New peptide derivatives that target the SARS-CoV-2 spike protein

Mathematical model reveals how cell turnover determines the success of adaptive therapy

One of the most challenging issues in cancer therapy is the development of drug resistance and subsequent disease progression.

NCOA spearheads new initiative to help protect older adults from influenza

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Prof Victor Ck Tse is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Prof Victor Ck Tse, MD PHD 1150 Veterans Blvd, Redwood City, CA 94063-2037 Ph: (206) 320-2800	Prof Victor Ck Tse, MD PHD 550 17th Ave, 5th Floor, Seattle, WA 98122-5788 Ph: (206) 320-2800

News Archive

Opioid, sedative and antidepressant use prior to surgery leads to more complications

New peptide derivatives that target the SARS-CoV-2 spike protein

Mathematical model reveals how cell turnover determines the success of adaptive therapy

One of the most challenging issues in cancer therapy is the development of drug resistance and subsequent disease progression.

NCOA spearheads new initiative to help protect older adults from influenza

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Neurological Surgery Doctors in Seattle, WA

George A Ojemann, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: University Of Washington Medical Ctr, 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-598-5637
Mr. Trent Lane Tredway, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 737 Olive Way Apt 2502, Seattle, WA 98101 Phone: 206-623-1334 Fax: 206-623-1677
Daniel A Lazar, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1560 N 115th St, 209, Seattle, WA 98133 Phone: 206-368-1701 Fax: 206-363-0019
Mohammed Basamh, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 550 17th Ave Ste 500, Seattle, WA 98122 Phone: 206-320-2451
Dr. Christoph Paul Hofstetter, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Campus Box 356470, Room Rr734, Seattle, WA 98195 Phone: 507-202-9523
David Keisho Su, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 Lenora St, 501, Seattle, WA 98121 Phone: 559-260-0047
Syed Shabaz Azeem, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 125 16th Ave E, Seattle, WA 98112 Phone: 206-326-3000

Prof Victor Ck Tse, MD PHD - Medicare Neurological Surgery in Seattle, WA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Opioid, sedative and antidepressant use prior to surgery leads to more complications

New peptide derivatives that target the SARS-CoV-2 spike protein

Mathematical model reveals how cell turnover determines the success of adaptive therapy

NCOA spearheads new initiative to help protect older adults from influenza

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Opioid, sedative and antidepressant use prior to surgery leads to more complications

New peptide derivatives that target the SARS-CoV-2 spike protein

Mathematical model reveals how cell turnover determines the success of adaptive therapy

NCOA spearheads new initiative to help protect older adults from influenza

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Opioid, sedative and antidepressant use prior to surgery leads to more complications

New peptide derivatives that target the SARS-CoV-2 spike protein

Mathematical model reveals how cell turnover determines the success of adaptive therapy

NCOA spearheads new initiative to help protect older adults from influenza

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Opioid, sedative and antidepressant use prior to surgery leads to more complications

New peptide derivatives that target the SARS-CoV-2 spike protein

Mathematical model reveals how cell turnover determines the success of adaptive therapy

NCOA spearheads new initiative to help protect older adults from influenza

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Neurological Surgery Doctors in Seattle, WA